...
首页> 外文期刊>Medicine. >Nomogram to Predict Occult N2 Lymph Nodes Metastases in Patients With Squamous Nonsmall Cell Lung Cancer
【24h】

Nomogram to Predict Occult N2 Lymph Nodes Metastases in Patients With Squamous Nonsmall Cell Lung Cancer

机译:NOMA图预测抗鳞状NONSMALL细胞肺癌患者中的胚芽N2淋巴结转移

获取原文
   

获取外文期刊封面封底 >>

       

摘要

For nonsmall cell lung cancer (NSCLC) patients without distant metastases, occult involvement of N2 lymph nodes would be of the utmost importance in determining both treatment and survival. The key to optimal treatment strategies relied on accurate diagnosis, in particular accurate clinical tumor staging. Patients with clinical N0 or N1 staging preoperatively had a sizeable risk to have occult N2 lymph nodes metastases. From November 2004 to March 2007, the entire database in a tertiary hospital of all patients with a pathologic diagnosis of squamous NSCLC underwent anatomical pulmonary resection and systematic mediastinal lymph node dissection were retrospectively collected and reviewed. A nomogram was developed on the basis of a multivariable logistic regression model with a combination of all potential variables. In order to surmount the potential of overestimating predictive performance, both bootstrapping for internal validation and an independent external validation set were employed. A nomogram incorporating the significant risk factors was created to predict the probability of occult N2 lymph nodes metastases. The calibration plot for the probability of occult N2 lymph nodes metastases showed an optimal agreement between the predicted probabilities by nomogram and actual observed probabilities. An objective and accurate nomogram predictive model for occult N2 lymph nodes metastases was drawn up and validated internally and externally in patients with squamous NSCLC. The nomogram model, as a robust tool in predicting occult N2 lymph nodes involvement, could be involved in a cost-effective application of specific diagnostic and therapeutic strategies.
机译:对于没有远处转移的非球体细胞肺癌(NSCLC)患者,神经涉及N2淋巴结的涉及对于确定治疗和存活是至关重要的。最佳治疗策略的关键依赖于准确的诊断,特别是准确的临床肿瘤分期。术前N0或N1术前分期的患者具有相当大的风险来具有潜水N2淋巴结转移。从2004年11月到2007年3月,所有患者在所有患者的鳞状NSCLC病理诊断患者的整个数据库都回顾性收集并审查了鳞状肺切除和系统纵隔淋巴结解剖。基于一个多变量的逻辑回归模型开发了一种铭文图,其中包括所有潜在变量。为了超越高估预测性能的可能性,采用了内部验证的自动启动和独立的外部验证集。创建了一种含有显着风险因素的载体,以预测隐匿N2淋巴结转移的概率。用于隐匿性N2淋巴结转移概率的校准图显示了通过墨顶图和实际观察到的概率之间的预测概率之间的最佳协议。在鳞状NSCLC患者的患者内和外部制定了潜水N2淋巴结转移的目标和准确的探测器预测模型。作为预测隐匿性N2淋巴结参与的鲁棒工具的载体模型可以参与特定诊断和治疗策略的成本效益。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号